Despite all the attention on technologies that reduce the hands-on role of humans at work — such as self-driving vehicles, robot workers, artificial intelligence, and so on — researchers in the field ...

Nearly half of advanced ovarian cancer patients relapsed after first-line PARP inhibitor maintenance, emphasizing the need for refined postrecurrence strategies. BRCA mutation carriers were more ...

Please provide your email address to receive an email when new articles are posted on . Reflectance confocal microscopy (RCM) has not been extensively studied in real-life practice. In a real-life ...

Ruxolitinib cream shows rapid, significant repigmentation in NSV, aligning with phase 3 trial outcomes and suggesting first-line therapy potential, especially for facial involvement. The study's ...